natgillin/translations-raw huggingface dataset:
The following entry ‘No 28’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 28“:
EC No: 227-424-0
št. ES: 227-424-0
CAS No: 5836-29-3
št. CAS: 5836-29-3
In view of the identified risks for non-target animals, the active substance shall be subject to a comparative risk assessment in accordance with the second subparagraph of Article 10(5)(i) of Directive 98/8/EC before its inclusion in this Annex is renewed.
Zaradi ugotovljenih tveganj za neciljne živali je treba pred ponovno vključitvijo te aktivne snovi v to prilogo izvesti primerjalno oceno tveganja v skladu z drugim pododstavkom člena 10(5)(i) Direktive 98/8/ES.
The nominal concentration of the active substance in products other than tracking powder shall not exceed 375 mg/kg and only ready-for use products shall be authorised.
Nazivna koncentracija aktivne snovi v pripravkih, razen v sredstvu za posipanje, ne presega 375 mg/kg, dovoljenje pa se izda samo za pripravke, ki se lahko takoj uporabijo.
These include, amongst others, the restriction to professional use only, setting an upper limit to the package size and laying down obligations to use tamper resistant and secured bait boxes.’
Ti med drugim vključujejo omejitev uporabe pripravka na zgolj poklicno, določitev največje velikosti embalaže in določitev zahtev za uporabo vab, zaščitenih pred nepooblaščenimi posegi.“
Commission Directive 2009/86/EC
Direktiva Komisije 2009/86/ES
amending Directive 98/8/EC of the European Parliament and of the Council to include fenpropimorph as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev fenpropimorfa kot aktivne snovi v Prilogo I k Direktivi
That list includes fenpropimorph.
Navedeni seznam vključuje fenpropimorf.
Pursuant to Regulation (EC) No 1451/2007, fenpropimorph has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 8, wood preservatives, as defined in Annex V to Directive 98/8/EC.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja fenpropimorfa glede uporabe v 8. vrsti izdelkov, pripravkih za zaščito lesa, kot je opredeljena v Prilogi V k Direktivi 98/8/ES.
Spain was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 4 December 2006 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Španija, ki je bila imenovana za državo članico poročevalko, je 4. decembra 2006 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 20 February 2009, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda v Stalnem odboru za biocidne pripravke 20. februarja 2009 vključene v poročilo o oceni.
It appears from the examinations made that biocidal products used as wood preservatives and containing fenpropimorph may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot pripravki za zaščito lesa in vsebujejo fenpropimorf, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include fenpropimorph in Annex I, in order to ensure that in all Member States authorisations for biocidal products used as wood preservatives and containing fenpropimorph can be granted, modified, or cancelled in accordance with Article 16(3) of Directive 98/8/EC.
Zato je primerno vključiti fenpropimorf v Prilogo I, da se v vseh državah članicah v skladu s členom 16(3) Direktive 98/8/ES zagotovi, da se izdajo, spremenijo ali razveljavijo dovoljenja za biocidne pripravke, ki se uporabljajo kot pripravki za zaščito lesa in vsebujejo fenpropimorf.
In the light of the findings of the assessment report, it is appropriate to require that risk mitigation measures are applied at product authorisation level to products containing fenpropimorph and used as wood preservatives to ensure that risks are reduced to an acceptable level in accordance with Article 5 of Directive 98/8/EC and Annex VI thereto.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se v skladu s členom 5 Direktive 98/8/ES in Prilogo VI k Direktivi pri izdaji dovoljenj za pripravke, ki vsebujejo fenpropimorf in se uporabljajo za zaščito lesa, uporabijo ukrepi za zmanjšanje tveganja, da se tveganje zmanjša na sprejemljivo raven.
In particular, appropriate measures should be taken to protect the soil and aquatic compartments since unacceptable risks to these compartments have been identified during the evaluation.
Zlasti je treba sprejeti ustrezne ukrepe za varovanje tal in vode, saj je bilo med presojo ugotovljeno nesprejemljivo tveganje za ta ekosistema.
Products intended for industrial use should be used with appropriate protective equipment if the risk identified for industrial users cannot be reduced by other means.
Pripravke, namenjene industrijski uporabi, je treba uporabljati z ustrezno zaščitno opremo, če tveganja za uporabnike v industriji ni mogoče zmanjšati z drugimi sredstvi.
It is therefore appropriate that Member States assess those risks to the compartments and populations that have not been representatively addressed in the Community level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to mitigate the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo tveganja za ekosisteme in prebivalce, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Skupnosti, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
It is important that the provisions of this Directive be applied simultaneously in all the Member States in order to ensure equal treatment of biocidal products on the market containing the active substance fenpropimorph and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov fenpropimorf, na trgu in da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC, and in particular, to grant, modify or cancel authorisations of biocidal products in product-type 8 containing fenpropimorph to ensure that they comply with Directive 98/8/EC.
Državam članicam je treba po vključitvi zagotoviti ustrezno obdobje za izvedbo člena 16(3) Direktive 98/8/ES in zlasti za izdajo, spremembo ali razveljavitev dovoljenj za biocidne pripravke v 8. vrsti izdelkov, ki vsebujejo fenpropimorf, da se zagotovi njihova skladnost z Direktivo 98/8/ES.
They shall apply those provisions from 1 July 2011.
Navedene predpise uporabljajo od 1. julija 2011.
The following entry ‘No 21’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 21“:
(+/-)-cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
(+/-)-cis-4-[3-(p-terc-butilfenil)-2-metilpropil]-2,6-dimetilmorfolin
EC No: 266-719-9
št. ES: 266-719-9
CAS No: 67564-91-4
št. CAS: 67564-91-4
When assessing the application for authorisation of a product in accordance with Article 5 and Annex VI, Member States shall assess, when relevant for the particular product, the populations that may be exposed to the product and the use or exposure scenarios that have not been representatively addressed at the Community level risk assessment.
Kadar je za določen pripravek to potrebno, države članice pri ocenjevanju vloge za izdajo dovoljenja za pripravek v skladu s členom 5 in Prilogo VI ocenijo tiste populacije, ki bi lahko bile izpostavljene pripravku, ter tiste scenarije uporabe ali izpostavljenosti, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Skupnosti.
Product authorisation can only be granted where the application demonstrates that risks can be reduced to acceptable levels.
Dovoljenje za pripravek se lahko izda samo v primeru, ko je v vlogi za izdajo dovoljenja dokazano, da je tveganja mogoče zmanjšati na sprejemljivo raven.
In view of the assumptions made during the risk assessment, products authorised for industrial use must be used with appropriate personal protective equipment, unless it can be demonstrated in the application for product authorisation that risks to industrial users can be reduced to an acceptable level by other means.
Glede na ugotovitve ocene tveganja je treba pripravke z dovoljenjem za industrijsko uporabo uporabljati z ustrezno osebno zaščitno opremo, razen če v vlogi za izdajo dovoljenja ni dokazano, da se tveganja za uporabnike v industriji lahko zmanjšajo na sprejemljivo raven z drugimi sredstvi.
In view of the risks identified for the soil and aquatic compartments, appropriate risk mitigation measures must be taken to protect those compartments.
Zaradi ugotovljenih tveganj za tla in vodo je treba za varovanje teh ekosistemov sprejeti ustrezne ukrepe za zmanjšanje tveganja.
In particular, labels and/or safety-data sheets of products authorised for industrial use shall indicate that freshly treated timber must be stored after treatment under shelter and/or on impermeable hard standing to prevent direct losses to soil or water and that any losses must be collected for reuse or disposal.’
Zlasti se na oznakah in/ali varnostnih listih pripravkov, katerih uporaba je dovoljena v industriji, navede, da je treba sveže obdelani les po obdelavi hraniti pod streho in/ali na neprepustni trdni podlagi, da se prepreči neposredno spiranje pripravkov v tla ali vodo, in da je treba omogočiti njihovo zbiranje za ponovno uporabo ali odstranitev.“
Commission Directive 2009/87/EC
Direktiva Komisije 2009/87/ES
amending Directive 98/8/EC of the European Parliament and of the Council to include indoxacarb as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev indoksakarba kot aktivne snovi v Prilogo I k Direktivi
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market [1], and in particular Article 11(4) thereof,
ob upoštevanju Direktive 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet [1] in zlasti člena 11(4) Direktive,
The United Kingdom (UK) has received on 12 December 2005 an application from DuPont de Nemours S.A., in accordance with Article 11(1) of Directive 98/8/EC, for the inclusion of the active substance indoxacarb in its Annex I or IA for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to Directive 98/8/EC.
Združeno kraljestvo je 12. decembra 2005 od DuPont de Nemours S.A. v skladu s členom 11(1) Direktive 98/8/ES prejelo predlog za vključitev aktivne snovi indoksakarba v njeno Prilogo I ali IA zaradi uporabe v 18. vrsti izdelkov, insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k Direktivi 98/8/ES.
Indoxacarb was not on the market on the date referred to in Article 34(1) of Directive 98/8/EC as an active substance of a biocidal product.
Indoksakarb pred datumom iz člena 34(1) Direktive 98/8/ES še ni bil v prometu kot aktivna snov biocidnega pripravka.
After carrying out an evaluation, the UK submitted a competent authority report, together with a recommendation, to the Commission on 5 March 2007.
Po opravljeni presoji je Združeno kraljestvo 5. marca 2007 Komisiji poslalo poročilo pristojnega organa in priporočilo.
The competent authority report was reviewed by the Member States and the Commission within the Standing Committee on Biocidal Products on 28 May 2008, and the findings of the review were incorporated in an assessment report.
Poročilo pristojnega organa so 28. maja 2008 v Stalnem odboru za biocidne pripravke pregledale države članice in Komisija, ugotovitve pregleda pa so bile vključene v poročilo o oceni.
It appears from the examinations made that biocidal products used as insecticides, acaricides or to control other arthropods and containing indoxacarb may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev ter vsebujejo indoksakarb, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include indoxacarb in Annex I.
Zato je primerno vključiti indoksakarb v Prilogo I.
In the light of the findings of the assessment report, it is also appropriate to require that risk mitigation measures are applied at product authorisation level to products containing indoxacarb and used as insecticides, acaricides or to control other arthropods.
Glede na ugotovitve poročila o oceni je primerno tudi zahtevati, da se pri izdaji dovoljenj za pripravke, ki vsebujejo indoksakarb in se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev, uporabijo ukrepi za zmanjšanje tveganja.
Such measures should be aimed at limiting the risks to non-target species and the aquatic environment.
Ti ukrepi morajo biti usmerjeni k omejitvi tveganja za neciljne vrste in vodno okolje.
To this end, certain conditions such as ensuring that products are not placed in areas accessible to infants, children and companion animals and do not enter into contact with water should be imposed.
Zato je treba predpisati nekatere pogoje, na primer da se pripravki ne hranijo na mestih, ki so dosegljiva dojenčkom, otrokom in hišnim živalim, ter da ne pridejo v stik z vodo.
A reasonable period should be allowed to elapse before an active substance is included in Annex I in order to permit Member States to bring into force the laws, regulations and administrative provisions necessary to comply with this Directive.
Pred vključitvijo aktivne snovi v Prilogo I je treba zagotoviti ustrezno obdobje, ki bo omogočilo državam članicam, da sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo.
The Standing Committee on Biocidal Products was consulted on 30 May 2008 and delivered a positive opinion on the draft Commission Directive amending Annex I of Directive 98/8/EC to include indoxacarb as an active substance.
Stalni odbor za biocidne pripravke, s katerim je bilo posvetovanje opravljeno 30. maja 2008, je dal pozitivno mnenje o osnutku Direktive Komisije, ki spreminja Prilogo I k Direktivi 98/8/ES z vključitvijo indoksakarba kot aktivne snovi.
On 11 June 2008 the Commission submitted the said draft for scrutiny by the European Parliament and the Council.
Komisija je 11. junija 2008 navedeni osnutek predložila v pregled Evropskemu parlamentu in Svetu.
The European Parliament did not oppose the draft measures within the set deadline.
Evropski parlament v postavljenem roku ni nasprotoval osnutku ukrepov.
The Council opposed the adoption by the Commission indicating that the proposed measures exceeded the implementing powers provided for in Directive 98/8/EC.
Svet je nasprotoval sprejetju ukrepa s strani Komisije, ker predlagani ukrepi presegajo izvedbena pooblastila, določena v Direktivi 98/8/ES.
As a consequence, the Commission did not adopt the draft measures and submitted an amended draft of the concerned Directive to the Standing Committee on Biocidal Products.
Komisija zato ni sprejela osnutka ukrepov in je spremenjeni osnutek zadevne direktive predložila Stalnemu odboru za biocidne pripravke.
The Standing Committee was consulted on the said draft on 20 February 2009.
Posvetovanje s Stalnim odborom o zadevnem osnutku je bilo opravljeno 20. februarja 2009.
Member States shall adopt and publish the laws, regulations and administrative provisions necessary to comply with this Directive not later than 6 months after its entry into force.
Države članice sprejmejo ter objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje v 6 mesecih po začetku njene veljavnosti.
The following entry ‘No 19’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 19“:
Indoxacarb (enantiomeric reaction mass S:R 75:25)
indoksakarb (reakcijska zmes S- in R-enantiomerov v razmerju 75:25)
Reaction mass of methyl (S)- and methyl(R)-7-chloro-2.3,4a,5-tetrahydro-2-[methoxycarbonyl-(4-trifluoromethoxyphenyl) carbamoyl]indeno[1,2-e][1.3,4]oxadiazine-4a-carboxylate (This entry covers the 75:25 reaction mass of the S and R enantiomers)
Reakcijska zmes metil-(S)- in metil-(R)-7-kloro-2,3,4a,5-tetrahidro-2-[metoksikarbonil-(4-trifluorometoksifenil) karbamoil]indeno[1,2-e][1,3,4]oksadiazin-4a-karboksilata (ta vnos zajema reakcijsko zmes S- in R-enantiomerov v razmerju 75:25)
EC No: n/a
št. ES: se ne uporablja
CAS No: S-enantiomer: 173584-44-6 and R-enantiomer: 185608-75-7)
št. CAS: S-enantiomer: 173584-44-6 in R-enantiomer: 185608-75-7
n/a
Se ne uporablja.
Appropriate risk mitigation measures must be taken to minimise the potential exposure of humans, of non-target species and of the aquatic environment.
Zaradi zmanjšanja možnosti izpostavljenosti ljudi, neciljnih vrst in vodnega okolja je treba sprejeti ustrezne ukrepe za zmanjšanje tveganja.
In particular, labels and/or safety-data sheets of products authorised shall indicate that:
Na oznakah in/ali varnostnih listih dovoljenih pripravkov se zlasti navede:
Products shall not be placed in areas accessible to infants, children and companion animals.
Pripravki se ne hranijo na mestih, ki so dosegljiva dojenčkom, otrokom in hišnim živalim.
Products shall be positioned away from external drains.
Pripravki se ne hranijo v bližini zunanjih odtokov.
Unused products shall be disposed of properly and not washed down the drain.
Neuporabljeni pripravki se ustrezno odstranijo in se ne izlivajo v odtok.
For amateur uses, only ready-to-use products shall be authorised.’
Za nepoklicno uporabo se dovolijo samo pripravki, ki so pripravljeni za takojšnjo uporabo.“
Commission Directive 2009/88/EC
Direktiva Komisije 2009/88/ES
of 30 July 2009
z dne 30. julija 2009
amending Directive 98/8/EC of the European Parliament and of the Council to include thiacloprid as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev tiakloprida kot aktivne snovi v Prilogo I k Direktivi
The United Kingdom (UK) has received on 20 February 2006 an application from Lanxess Deutschland GmbH, in accordance with Article 11(1) of Directive 98/8/EC, for the inclusion of the active substance thiacloprid in its Annex I or IA for use in product-type 8, wood preservatives, as defined in Annex V to Directive 98/8/EC. thiacloprid was not on the market on the date referred to in Article 34(1) of Directive 98/8/EC as an active substance of a biocidal product.
Združeno kraljestvo je 20. februarja 2006 od Lanxess Deutschland GmbH v skladu s členom 11(1) Direktive 98/8/ES prejelo predlog za vključitev aktivne snovi tiakloprida v njeno Prilogo I ali IA zaradi uporabe v 8. vrsti izdelkov, pripravkih za zaščito lesa, kot je opredeljena v Prilogi V k Direktivi 98/8/ES. Tiakloprid pred datumom iz člena 34(1) Direktive 98/8/ES še ni bil v prometu kot aktivna snov biocidnega pripravka.
After carrying out an evaluation, the UK submitted a competent authority report, together with a recommendation, to the Commission on 3 July 2007.
Po opravljeni presoji je Združeno kraljestvo 3. julija 2007 Komisiji poslalo poročilo pristojnega organa in priporočilo.
It appears from the examinations made that biocidal products used as wood preservatives and containing thiacloprid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot pripravki za zaščito lesa in vsebujejo tiakloprid, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include thiacloprid in Annex I.
Zato je primerno vključiti tiakloprid v Prilogo I.
However, unacceptable risks were identified for the in situ treatment of wooden structures near water, where direct losses to the aquatic compartment cannot be prevented.
Vendar so bila ugotovljena nesprejemljiva tveganja za obdelavo lesenih konstrukcij na kraju samem, kadar so te blizu vode, saj ni mogoče preprečiti neposrednih izgub v vodni ekosistem.
In the light of the findings of the assessment report, it is appropriate to require that risk mitigation measures are applied at product authorisation level to products containing thiacloprid and used as wood preservatives to ensure that risks are reduced to an acceptable level in accordance with Article 5 of Directive 98/8/EC and Annex VI thereto.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se v skladu s členom 5 Direktive 98/8/ES in Priloge VI k Direktivi pri izdaji dovoljenj za pripravke, ki vsebujejo tiakloprid in se uporabljajo za zaščito lesa, uporabijo ukrepi za zmanjšanje tveganja, da se tveganja zmanjšajo na sprejemljivo raven.
Products intended for industrial and/or professional use should be used with appropriate protective equipment if the risk identified for industrial and/or professional users cannot be reduced by other means.
Pripravke, namenjene industrijski in/ali poklicni uporabi, je treba uporabljati z ustrezno zaščitno opremo, če tveganja za porabnike v industriji in/ali strokovne uporabnike ni mogoče zmanjšati z drugimi sredstvi.
The Standing Committee on Biocidal Products was consulted on 30 May 2008 and delivered a positive opinion on the draft Commission Directive amending Annex I to Directive 98/8/EC to include thiacloprid as an active substance.
Stalni odbor za biocidne pripravke, s katerim je bilo posvetovanje opravljeno 30. maja 2008, je dal pozitivno mnenje o osnutku direktive Komisije, ki spreminja Prilogo I k Direktivi 98/8/ES z vključitvijo tiakloprida kot aktivne snovi.
Done at Brussels, 30 July 2009.
V Bruslju, 30. julija 2009
The following entry ‘No 18’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 18“:
CAS No: 111988-49-9
št. CAS: 111988-49-9
In view of the assumptions made during the risk assessment, products authorised for industrial and/or professional use, must be used with appropriate personal protective equipment, unless it can be demonstrated in the application for product authorisation that risks to industrial and/or professional users can be reduced to an acceptable level by other means.
Glede na ugotovitve ocene tveganja je treba pripravke z dovoljenjem za industrijsko in/ali poklicno uporabo uporabljati z ustrezno osebno zaščitno opremo, razen če je v vlogi za izdajo dovoljenja dokazano, da se tveganja za uporabnike v industriji in/ali strokovne uporabnike lahko zmanjšajo na sprejemljivo raven z drugimi sredstvi.
In view of the risks identified for the soil and aquatic compartments appropriate risk mitigation measures must be taken to protect those compartments.
Zaradi ugotovljenega tveganja za tla in vodo je treba za varovanje teh ekosistemov sprejeti ustrezne ukrepe za zmanjšanje tveganja.